![Daniel Javitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 31/05/2026
Daniel C.
Javitt is associated with NeuroRx, Inc. as a Co-Chairman since 2015.
He is the founder of NeuroRx, Inc. which was founded in 2015.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NRX Pharmaceuticals, Inc.
 NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company 4,05 % | 12/02/2026 | 963.480 ( 4,05 % ) | 4 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of central nervous system disorders | Fundador | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of central nervous system disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
